HUTCHMED unveils its innovative ATTC platform, potentially providing precision oncology with synergistic dual-mechanism of action - ...

The study will test the antibody-drug conjugate in combination with Keytruda in patients with HER2-overexpressing metastatic non-small cell lung cancer.

Ajinomoto Co., Inc. has signed a licensing agreement with Astellas Pharma Inc. for the use of AJICAP—an antibody-drug conjugate (ADC) development and manufacturing technology—as part of its CDMO ...

Shares of Intensity Therapeutics Inc. (NASDAQ:INTS) tumbled nearly 30% on Friday after the late-stage biotech firm announced ...

NetTargets employs an AI system that combines multi-omics data with neural network modelling for drug discovery.

An Oxford-led study has demonstrated that an oral live-attenuated vaccine, CVD 1902, provided significant protection against S. Paratyphi A infection in healthy adults using a controlled human ...

The company's outlook for the rest of the year was rosier than in the previous quarter, when it announced a cost-cutting plan ...

Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and ...

The U.S. Food and Drug Administration (FDA) has granted fast track designation to the antibody-drug conjugate JSKN003 for the ...

Agreement expands Piramal’s payload-linker platform and bioconjugate abilities.

Presentations to highlight ongoing clinical and translational research across PDS Biotechnology’s immunotherapy platforms ...

Advancing AT-01, a first-in-class ADC programme, with strong preclinical validation towards IND/CTA-enabling studies, expected to begin in the first half of 2026 Leadership and Board strengthened with ...